India's Healthcare Shift: Phydigital Patient Programs Drive Growth

OTHER
Whalesbook Logo
AuthorAarav Shah|Published at:
India's Healthcare Shift: Phydigital Patient Programs Drive Growth
Overview

India's healthcare sector is undergoing a significant transition, moving value creation from hospitals to continuous patient engagement. The rise of 'phydigital' healthcare, blending physical care with digital tools, is transforming patient support programs into a scalable business model. This approach addresses critical challenges in managing chronic diseases, improves treatment adherence, and expands access to healthcare services beyond major cities.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

The 'Phydigital' Integration

India's healthcare is shifting from an episodic, hospital-centered model to one focused on ongoing patient journeys. The 'phydigital' approach is leading this change, blending in-person medical care with digital tools. This hybrid strategy extends patient care beyond the clinic, offering ongoing support for treatment adherence and lifestyle management.

Driving Forces and Challenges

The rising prevalence of chronic diseases like diabetes, heart conditions, and respiratory disorders requires long-term management strategies. Patients often discontinue treatment due to factors like lack of awareness, cost concerns, or insufficient follow-up. "Patients need continuous support, especially in chronic conditions where long-term management is critical," notes Mahesh Makhija, Founder, Chairman and Managing Director of QMS Medical Allied Services. This gap in consistent care presents a significant opportunity for new business models.

Monetizing Patient Engagement

What began as patient assistance is evolving into a structured business vertical. Patient Service Programmes (PSPs) are now being adopted by pharmaceutical firms, healthcare providers, and specialized service companies. The goal is to enhance treatment adherence, leading to better patient outcomes and increased lifetime value per patient. "Early data suggests strong traction. Structured programmes that combine counselling, reminders and lifestyle guidance have shown significantly higher retention rates over six to twelve months, particularly in chronic therapies," Makhija stated. This translates into predictable demand, improved brand loyalty, and deeper patient insights for companies.

Expanding Reach Beyond Metros

Growth is accelerating as healthcare access expands into Tier-2 and Tier-3 cities, driven by increasing digital penetration and widespread smartphone use. "Programmes are increasingly being tailored to local needs, including language preferences, cultural nuances and varying levels of digital literacy. WhatsApp, in particular, has emerged as a key engagement tool due to its familiarity and ease of use," Makhija explained. This localisation, combined with scalable digital infrastructure, allows companies to build nationwide patient networks cost-effectively.

Easing Doctor Bandwidth

These structured programs offer a solution to the critical constraint of limited doctor time. By delegating routine follow-ups and patient education to PSPs, healthcare providers can dedicate more time to complex interventions. "In the future, healthcare will not just be about treating patients but staying connected with them throughout their journey," says Makhija. "Patient programmes will become the backbone of that connected-care ecosystem."

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.